Abdominal Neoplasms Clinical Trial
Official title:
Determination of Optimal Dose and Safety Profile of Optison Ultrasound Contrast Agent in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital is studying ways to make ultrasound images clearer -
to be able to see blood vessels, body structures, and tumors better. Ultrasound uses sound
waves to create pictures, allowing doctors and other medical professionals to "see" inside
the body.
Researchers are studying a contrast agent (like a dye) called Optison™. St. Jude Children's
Research Hospital researchers want to learn the best and safest dose of this ultrasound
"dye."
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Completed |
NCT00385177 -
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT00191646 -
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
|
Phase 3 | |
| Recruiting |
NCT03622983 -
Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
|
||
| Completed |
NCT01103492 -
Treatment of Hemorrhagic Radiation Proctitis Using the Halo System
|
N/A | |
| Completed |
NCT00191607 -
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
|
Phase 3 | |
| Recruiting |
NCT02557256 -
Malignant Pediatric Pelvic Tumors: A Retrospective Study
|